MDeyes Once Daily macular defence formula simplified AREDS 2 supplementation when it launched in February this year. Delivering a complete AREDS 2 low zinc formula, MDeyes includes the specific quality ingredients used in the AREDS 2 clinical trial, at the correct daily dosage, and features FloraGLO Lutein and OPTISHARP Zeaxanthin,” a company spokesman says.
“The Once Daily dosage of MDeyes is a major step toward ensuring compliance. Compliance Prompting Packaging with calendarised labeling on the blister foil and a grid on the back of each pack further supports patient compliance.”
MDeyes is only available through eye care professionals and is not sold through pharmacies.
MDeyes is Australian made and owned by Phasem Health, a company bringing quality, evidence-based products to the Australian healthcare market at affordable prices.
MDeyes proudly supports Optometry Giving Sight, with a percentage of all sales donated to the global vision initiative.
Contact: Phasem Health (AUS) 1300 95 2001